• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • iPSC Quality Assessment Rounds
    • iPSC Quality Assessment Round 2022/2023
      • iPSC Quality Assessment Round 2022 – Document Page
  • Directories
  • Clinical Database
  • Portal Login
You are here: Home / Retired GAiT Director – Cell Gene Therapy Catapult

Retired GAiT Director – Cell Gene Therapy Catapult

GAiT Director (Retired) Professor Johan Hyllner

Prof. Hyllner was a GAiT director from May 2014- November 2017. He retired from the position in November 2017 and was replaced by Dr. Jacqueline Barry.

Johan was Chief Scientific Officer of the Cell and Gene Therapy Catapult (May 2013-March 2018). As Chief Scientific Officer, he is responsible for external scientific relations, assessment of candidate projects and technical oversight of preclinical programmes.

Johan has extensive experience of the life sciences industry, having worked in cell and tissue companies in Europe and the US for over 15 years. Johan has been involved in numerous transactions and collaborations, establishment of scientific facilities, and the management of scientific programmes in industry and academia. Johan has a PhD from the University of Gothenburg in Sweden and is currently adjunct professor at Linköping University in Sweden.

Read a transcript of his exit interview here.

Primary Sidebar

Search Users

Secondary Sidebar

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2023 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login